These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27591943)

  • 41. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW; Wang SS; Tsai WJ
    Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation.
    Margaroni M; Agallou M; Kontonikola K; Karidi K; Kammona O; Kiparissides C; Gaitanaki C; Karagouni E
    Eur J Pharm Biopharm; 2016 Aug; 105():18-31. PubMed ID: 27235727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
    Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
    J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform.
    Yamamoto H; Tahara K; Kawashima Y
    J Microencapsul; 2012; 29(1):54-62. PubMed ID: 22034956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
    Jeon SY; Park JS; Yang HN; Woo DG; Park KH
    Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
    Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
    J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.
    Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A
    J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A.
    Guldner D; Hwang JK; Cardieri MC; Eren M; Ziaei P; Norton MG; Souza CD
    PLoS One; 2016; 11(11):e0165477. PubMed ID: 27835636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
    J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment.
    Zhang X; Dong Y; Zeng X; Liang X; Li X; Tao W; Chen H; Jiang Y; Mei L; Feng SS
    Biomaterials; 2014 Feb; 35(6):1932-43. PubMed ID: 24315578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.
    Portioli C; Bovi M; Benati D; Donini M; Perduca M; Romeo A; Dusi S; Monaco HL; Bentivoglio M
    J Biomed Mater Res A; 2017 Mar; 105(3):847-858. PubMed ID: 27885823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
    Joshi SA; Chavhan SS; Sawant KK
    Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
    O'Donnell A; Moollan A; Baneham S; Ozgul M; Pabari RM; Cox D; Kirby BP; Ramtoola Z
    J Pharm Pharmacol; 2015 Apr; 67(4):525-36. PubMed ID: 25515568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
    Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
    Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
    Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A
    Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
    Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.